参考文献/References:
[1] Mariani G, Bodei L, Adelstein SJ, et al. Emerging roles for radiometabolic therapy of tumors based on auger electron emission[J]. J Nucl Med, 2000, 41(9):1519-1521.
[2] Partensky C, Sassolas G, Henry L, et al. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma:a phase 2 clinical study[J]. Arch Surg, 2000, 135(11):1298-1300.
[3] Larsen SW, Rinvar E, Svendsen O, et al. Determination of the disappearance rate of iodine-125 labelled oils from the injection site after intramuscular and subcutaneous administration to pigs[J]. Int J Pharm, 2001, 230(1):67-75.
[4] Blasco JC. Brachytherapy[J]. Urology, 2000, 55(2):306-308.
[5] Boland A, Ricard M, Opolon P, et al. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy[J]. Cancer Res, 2000,60(13):3484-3492.
[6] Krishnamurthy GT, Swailem FM, Swailem SC, et al. Tin117(4+)DTPA:Pharmacokinetics and imaging characteristics in patients with metastatic bone pain[J]. J Nucl Med,1997, 38(2):230-235.
[7] Goddu SM, Bishayee A, Bouchet LG, et al. Marrow toxicity of 33P-versus 32P-orthophosphate:implications for therapy of bone pain and bone metastases[J]. J Nucl Med, 2000, 41(5):941-951.
[8] Makhija S, Howden N, Edwards R, et al. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma:a retrospective review[J]. Gynecol oncol, 2002, 85(1):53-58.
[9] Yu JF, Yin DZ, Min XF, et al.(188Re)Rhenuim sulfide suspensio n:a potential radiopharmaceutical for treatment folowing intratumor injection[J]. Nucl Med Biol, 1999, 26:(5) 573-579.
[10] Nijsen F, Rook D, Brandt C, et al. Targeting of liver tumor in rats by selective delivery of holmium-166 loaded microsphers:a biodistribution study[J]. J Eur Nucl Med, 2001,28(6):743-749.
[11] Jacobs A, Tjuvajev JG, Dubrovin M, et al. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo[J]. Cancer Res,2001, 61(7):2983-2995.
[12] de Jong M, Breeman WAP, Bernard WA, et al.[177LuDOTA0, Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy[J]. Int J Cancer, 2001, 92(5):628-633.
[13] Eisenwiener KP, Prata MI, Buschmann I, et al. NODAGATOC, a new chelator-coupled somatostatin analogue labeled with[67Ga/68Ga] and 111In for SPECT, PET, and targeted therapeutic applications of somatostatin receptor(hsst2)expressing tumors[J]. Bioconjug Chem, 2002,13(3):530-541.
[14] Janson ET, Westlin JE, Ohrvall U, et al. Nuclear localization of 111In after intravenous injection of [111In-DTPA-DPhe1]-octreotide in patients with neuroendocrine tumors[J].J Nucl Med, 2000, 41(9):1514-1518.
相似文献/References:
[1]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[2]甘红梅,乔晋萍,孔爱英,等.正电子放射性显像剂代谢及其研究方法进展[J].国际放射医学核医学杂志,2010,34(2):65.[doi:10.3760/cma.j.issn.1673-4114.2010.02.001]
GAN Hong-mei,QIAO Jin-ping,KONG Ai-ying,et al.The progress on researching method and metabolism of positron radiopharmaceutical[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):65.[doi:10.3760/cma.j.issn.1673-4114.2010.02.001]
[3]顾涛颖,石洪成.放射性药物治疗肿瘤骨转移性骨痛的作用[J].国际放射医学核医学杂志,2010,34(2):88.[doi:10.3760/cma.j.issn.1673-4114.2010.02.006]
GU Tao-ying,SHI Hong-cheng.The use of radiopharmaceuticals for metastatic bone pain in cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):88.[doi:10.3760/cma.j.issn.1673-4114.2010.02.006]
[4]周雪,乔晋萍,孔爱英,等.受体结合实验及其在放射性显像剂研究中的应用进展[J].国际放射医学核医学杂志,2010,34(6):321.[doi:10.3760/cma.j.issn.1673-4114,2010.06.001]
ZHOU Xue,QIAO Jin-ping,KONG Ai-ying,et al.Progress on the application of ligand receptor binding assays in radiopharmaceuticals[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):321.[doi:10.3760/cma.j.issn.1673-4114,2010.06.001]
[5]彭添兴,吴华.18F-氟脱氧葡萄糖以外新型PET肿瘤显像剂[J].国际放射医学核医学杂志,2007,31(1):9.
PENG Tian-xing,WU Hua.New type PET imaging agent excluding 18F-fluorodeoxyglucose in oncology[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(1):9.
[6]陈璟,吴华.核素炎症显像的研究进展[J].国际放射医学核医学杂志,2003,27(3):107.
CHEN Jing,WU Hua.The development of radionuclide imaging of infection and inflammation[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(1):107.
[7]杨建权,李晔,张现忠.基于小分子肽的放射性药物[J].国际放射医学核医学杂志,2003,27(4):157.
YANG Jian-quan,LI Ye,ZHANG Xian-zhnng.Peptide as carrier for diagnosis and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(1):157.
[8]刘英,陈龙华,巩湘浩,等.VEGF与肿瘤的放射治疗[J].国际放射医学核医学杂志,2003,27(4):183.
LIU Ying,CHEN Long-hua,GONG Xiang-hao,et al.VEGF and radiation sensibitity[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(1):183.
[9]杨柳.组织多肽特异性抗原的临床意义[J].国际放射医学核医学杂志,2003,27(5):216.
YANG Liu.Clinical value of tissue polypeptide specific antigen[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(1):216.
[10]谷晓云.核医学诊断操作中的亚细胞水平吸收剂量及其生物效应[J].国际放射医学核医学杂志,2001,25(4):165.
GU Xiao-yun.Cellular dosimetry and biological conseuences caused by diagnostic nuclear medicine[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(1):165.